Grant: CIHR Fellowship
Direct Payment
$150,000.00
Protection against cardiac damage in the living heart by mitochondrial protein S-nitrosation: fundamental and therapeutic implications
FY 2011-12
Summary
Ischemia-reperfusion (IR) injury comprises the tissue damage and dysfunction caused by the removal and subsequent reintroduction of oxygenated blood supply. These pathologies are by far the leading cause of death in the world, including most prevalently the injuries from myocardial infarction (heart attack). Additionally, in the clinical context of surgery and organ transplantation, IR damage is unavoidable and detrimental to patient outcomes. Nitric oxide (NO) is cardioprotective during IR, encouraging the development of NO donors as drugs, however none has proven clinically useful and the protective mechanism remains elusive.
This project will build on the findings from my PhD work from which I discovered a central mechanism of damage during heart attacks that could be targeted and protected against using a novel NO-derived therapeutic drug. Uniquely, this drug protects when given intravenously at a time corresponding to when those suffering from heart attack typically receive medical attention. This project will build on this very exciting initial finding to understand how to protect against heart attack damage in the clinic, as well as through lifestyle and dietary interventions that encourage the same mechanism of protection. This will set the stage for clinical trials for tissue protection from heart attack, for which no drug currently exists. Also, it will greatly inform strategies for preventative lifestyle interventions against heart-attack damage.
Department
Program
CIHR Fellowship
Recipient
Location
United Kingdom
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
255089
Name
Chouchani Edward T
Country
United Kingdom
Orgtype
Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Protection against cardiac damage in the living heart by mitochondrial protein S-nitrosation: fundamental and therapeutic implications
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Cardioprotection; Mitochondria; Myocardial Infarction Therapy; Nitric Oxide; Oxidative Stress; Proteomics
Abstract
Ischemia-reperfusion (IR) injury comprises the tissue damage and dysfunction caused by the removal and subsequent reintroduction of oxygenated blood supply. These pathologies are by far the leading cause of death in the world, including most prevalently the injuries from myocardial infarction (heart attack). Additionally, in the clinical context of surgery and organ transplantation, IR damage is unavoidable and detrimental to patient outcomes. Nitric oxide (NO) is cardioprotective during IR, encouraging the development of NO donors as drugs, however none has proven clinically useful and the protective mechanism remains elusive.
This project will build on the findings from my PhD work from which I discovered a central mechanism of damage during heart attacks that could be targeted and protected against using a novel NO-derived therapeutic drug. Uniquely, this drug protects when given intravenously at a time corresponding to when those suffering from heart attack typically receive medical attention. This project will build on this very exciting initial finding to understand how to protect against heart attack damage in the clinic, as well as through lifestyle and dietary interventions that encourage the same mechanism of protection. This will set the stage for clinical trials for tissue protection from heart attack, for which no drug currently exists. Also, it will greatly inform strategies for preventative lifestyle interventions against heart-attack damage.
Competitiondate
201202
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Chouchani, Edward T
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~